Publications found:
37,045
Sort by:
Cempra: “GAIN from Drugs for Bad Bugs”
US$ 140.00
Drug resistance is a growing concern worldwide and Cempra (CEMP) is one of our lead recommendations ... offer an attractive investment opportunity in this therapy class. CEMP’s lead drug, 1. Solithromycin (CEM-101, PhIII, CABP; PhII cUTI) ... released on 2nd July, 2012 on CEMP titled “GAIN from Drugs for Bad Bugs”
July 2012
9 pages
Competitor Analysis: Dengue Virus Vaccines and Therapeutics
US$ 243.00
... of Dengue fever and of therapeutics for treatment of Dengue fever. In addition, the report lists company-specific R&D pipelines of Dengue Virus Vaccines & Therapeutics. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target / Mechanism of Action, Class of Compound, ...
July 2012
27 pages
China Genetic Engineering Drug Industry Report, 2011-2012
US$ 1,900.00
China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...
June 2012
80 pages
Medical Laboratories: Market Research Report
US$ 4,800.00
... report analyzes the worldwide markets for Medical Laboratories in US$ Million by the following Product Segments: Hospital-Based Medical Laboratories, and Others. The ... through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 162 companies including many key and ...
June 2012
682 pages
Needle-Free Drug Injection Systems and Safety Syringes: Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides ... , Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, ...
June 2012
504 pages
Pharma sales force shape, size and structure — where next?
US$ 595.00
... — Pharma sales force shape, size and structure — where next? — analyses the key issues influencing sales force objectives and structure; how some pharma companies have restructured their sales and marketing channels, and whether these changes have been successful or not. Report Overview Pharma sales force shape, size ...
June 2012
68 pages
Pharma Leader Series: Top 20 Antibacterial Drug Manufacturers 2012-2022
US$ 2,635.00
Report Details Antibacterial medicines - discover performance and commercial prospects of companies How are leading companies in the antibacterial drugs market performing? Visiongain's new report gives you data, analyses and revenue predictions for antibacterial manufacturers. See how top companies ...
June 2012
185 pages
Onyx Pharma – Kyprolis to Accelerate Growth
US$ 140.00
... events – cardiovascular toxicities and deaths associated with Kyprolis as expected. ONXX has finally succeeded in ... Nexavar (L, RCC, HCC, partnered with Bayer), Kyprolis, and Regorafenib (R, oral multi-kinase inhibitor, GIST ... on Jun 21, 2012 on Onyx Pharma titled “Onyx Pharma - Kyprolis to Accelerate Growth”
June 2012
4 pages
Prioritizing Generic Drug development pipeline – The top Fifty Opportunities
US$ 5,000.00
... crucial aspects of growth strategy for a generic company or an Active Pharmaceutical Ingredient manufacturing ... recently approved or are in late stage development / Filed but with significantly success probability ... / therapeutic value compared to marketed drugs Anticipated competition in the therapy and ...
June 2012
100 pages
OTC Drug Market in India 2012
US$ 950.00
... days after order is placed. Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position ... tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign ...
June 2012
85 pages
World OTC Pharmaceutical Market 2012-2022
US$ 2,635.00
... , 35 charts and two research interviews. Nine ways World OTC Pharmaceutical Market 2012-2022 helps you In particular, our study gives ... , and others, discovering activities and outlooks Review prospects for Rx-to-OTC switching by therapeutic area Investigate competition and opportunities influencing sales ...
June 2012
147 pages
Production Situation of Vitamin E in China
US$ 1,620.00
In volume of transaction, Vitamin E is one of the world's top three vitamins with annual global market volume of nearly USD1 billion, thanks to the wide range of applications in feed, medicine and foo...
June 2012
20 pages
Competitor Analysis: RSV Vaccines and Therapeutics
US$ 315.00
Competitor Analysis: Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics The present Competitive Intelligence Report about RSV Vaccines & Therapeutics provides a ... RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number ...
June 2012
30 pages
Asia Pacific Pharma Sector Analysis
US$ 1,300.00
The Asia-Pacific region is emerging as the fastest growing pharmaceutical industry in the global pharmaceutical arena. In the recent years, the demand for healthcare services has risen among the regio...
May 2012
160 pages
The Chinese R&D Landscape - Pharmaceuticals
US$ 1,200.00
R&D in China in the field of pharmaceuticals* has surged over the last decade. This report seeks to answer the following questions related to this surge in R&D:
Where in China does the R&a...
May 2012
12 pages
Effective Sales and Marketing Strategies for Orphan Drugs
US$ 695.00
The real potential for orphan drug pharma marketing With drug pipelines moving from essential products to niche therapies, large pharma companies are increasingly attracted to the prospective high de...
May 2012
117 pages
Insulin Market Forecast to 2015
US$ 400.00
In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global mar...
May 2012
42 pages
Calming and Sleeping in Thailand
US$ 990.00
Claiming and sleeping products was previously present in Thailand in the form of some herbal calming and sleeping products, such as Baracol, Calmaco, Passiflora and Cassia ... . Consequently, these herbal calming and sleeping products was banned for sale over the counter... Euromonitor International's Calming and Sleeping in Thailand report offers a comprehensive ...
May 2012
23 pages
Emergency Contraception in Slovakia
US$ 990.00
... as a regular method of contraception. An overall decrease in value growth was evident each year as a result of changing lifestyles of females. In general emergency contraception is considered a last resort for many women as such medication has the... Euromonitor International's Emergency Contraception in Slovakia report offers a comprehensive ...
May 2012
20 pages
World Market for Over The Counter (OTC) Drugs, The
US$ 3,995.00
... more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers ... marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level. The base year ...
May 2012
190 pages
Hepatitis Treatments and Vaccines: World Market 2012-2022
US$ 2,635.00
... all-oral, interferon-free regimens with improved efficacy over present treatments. Companies are developing oral antiviral combinations, with launches expected ... 80 tables, 64 charts and a research interview. Eight ways Hepatitis Treatments and Vaccines: World Market 2012-2022 helps you In particular, our ...
May 2012
183 pages
Competitor Analysis: Pseudomonas Aeruginosa Vaccines and Therapeutics
US$ 394.00
The present Competitive Intelligence Report about Pseudomonas aeruginosa Vaccines & Therapeutics provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, peptides and small molecules as well as DNA-, RNA- and microorganism-based therapies against infection with ...
May 2012
46 pages
Kidney Cancer Drugs: Market Research Report
US$ 4,500.00
... report analyzes the worldwide markets for Kidney Cancer Drugs in US$ Million. This report on 'Kidney Cancer Drugs' provides market analytics specifically for ... Ltd., GlaxoSmithKline Plc, Merck-Serono, Novartis AG, Pfizer, Inc., and WILEX AG. Market data and analytics are derived from primary and secondary ...
April 2012
297 pages
Calming and Sleeping in Taiwan
US$ 990.00
Calming and sleeping remained insignificant in 2011, as calming and sleeping products were only available on prescription in Taiwan during the review period. Euromonitor International's Calming and Sleeping in Taiwan report ... . Why buy this report? Get a detailed picture of the Calming and Sleeping market; Pinpoint growth sectors and identify factors driving change ...
April 2012
17 pages
Cardiovascular Pharmaceuticals Market in India 2012
US$ 950.00
... days after order is placed. Cardiovascular pharmaceuticals market in India is the second largest contributor to domestic pharmaceutical sales, contributing around 15.6%. Since India has a huge patient pool, the ...
April 2012
71 pages
2012 Global Drugs of Abuse Testing Market Outlook: Growth Opportunities and Strategies
US$ 6,000.00
... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...
April 2012
311 pages
China's Pharmaceutical Industry 2011
US$ 600.00
This report describes the general development of China’s pharmaceutical industry in aspects of investment, production, sales, import & export, major prices and operations.
April 2012
15 pages
Smoking Cessation Drugs: World Market Prospects 2012-2022
US$ 2,633.00
... . R&D is promising. New formulations and generics will be important too. Innovations in drug delivery and rising demand in developing countries will also stimulate ... , 29 charts and three research interviews. Eight ways Smoking Cessation Drugs: World Market Prospects 2012-2022 helps you In particular, our ...
April 2012
116 pages
Clinical Trials Market in India 2012
US$ 950.00
... into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also ...
April 2012
58 pages
Emergency Contraception in Belarus
US$ 990.00
... be used under medical supervision. Most of the hormonal contraceptive medicines in Belarus are Rx products. Euromonitor International's Emergency Contraception in Belarus report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
April 2012
19 pages
NRT Smoking Cessation Aids in Belarus
US$ 990.00
... to lower the smoking rate. Heart disease accounts for some 88% of deaths from smoking-related illnesses in Belarus. Other... Euromonitor International's NRT Smoking Cessation Aids in Belarus report offers a comprehensive ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
April 2012
24 pages
Global Drugs Retail Industry 2012 - 2017: Trend, Profit, and Forecast Analysis
US$ 1,980.00
... the Global Drug Retail market and presents its findings in “Global Retail Drug Industry 2012-2017: Trend, Profit, and Forecast Analysis.” The drug industry consists of pharmacies and drug ... (Q1 2012 – Q4 2012) for global drugs retail industry analysis Gross and net profit trends in the global drugs retail industry analysis Cost structure trend in the global as well as regional global drugs retail industry ...
April 2012
RNA Interference (RNAi): Market Research Report
US$ 4,800.00
This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target ... , Inc., Exiqon A/S, Genesis Research & Development Corporation Limited, Halo-Bio RNAi Therapeutics, Inc., Marina Biotech, Inc., OPKO Health, Inc., Polyplus- ...
March 2012
792 pages
The World Anesthesia Drug Market (General, Local, Adjunctive)
US$ 3,995.00
This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies ... several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which ...
March 2012
190 pages
Research Report on Chinese Bio-pharmaceutical Industry, 2012
US$ 3,000.00
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In...
March 2012
60 pages
Compulsory License: India Pharma’s solution to “Patent and Affordability”
US$ 140.00
Recently, Natco was granted the first Compulsory License in India for the anti-cancer drug ‘Nexavar’. In an early test of India’s requirement that patent monopolies will ... now give rise to opportunities for other large cap global pharma companies too, as they can also seek a CL for other best ...
March 2012
8 pages
Calming and Sleeping in Bolivia
US$ 990.00
During the review period, consumer lifestyles in Bolivia became busier and more stressful due to economic development, longer ... complaints, these trends continued to drive demand for calming and sleeping products in... Euromonitor International's Calming and Sleeping in Bolivia report offers a comprehensive guide to the size ...
March 2012
21 pages
